In the BioHarmony Drug Report Database
Phexxi (lactic acid) is a small molecule pharmaceutical. Lactic acid was first approved as Phexxi on 2020-05-22. It is used to treat dermatitis and facial dermatoses in the USA. It is known to target hydroxycarboxylic acid receptor 1. Prismasol bgk2/0’s patents are valid until 2033-03-15 (FDA).
Image (chem structure or protein)